Default company panoramic image


Bone-Rad has developed a Brachytherapy Bone Cement that simplifies the treatment of bone tumors, reduces cost, and improves patient QOL.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Irvine, CA, USA
  • Currency USD
  • Employees 1
  • Website

Company Summary

Bone-Rad's first product, Spine-Rad, will treat vertebral tumors. The current treatment for vertebral tumors is kyphoplasty to strengthen the bone followed by 10-20 visits for external radiation therapy to kill the tumor. Spine-Rad Brachytherapy Bone Cement both strengthens the bone and kills the tumor in one step. External radiation therapy is not required, eliminating the associated side effects and expense, and improving patient QOL.


  • Default avatar
    Craig Fortier
    President / CEO

    Mr. Fortier has worked in the Medical Device business for over 25 years with much of that experience in start-up companies. Experience includes: Director of Strategic Marketing for Lumeins, V.P. Sales and Marketing at FzioMed, Global Marketing Manager at UroSurge, Product Manager at Biopsys Medical. Mr. Fortier has an undergraduate degree in Biochemistry from U.C. Berkeley and an MBA from UCLA’s Anderson Graduate School of Management.

  • Default avatar
    Steve Naber
    Chairman of the Board

    Mr. Naber has been involved with the financing and operations of start-up medical device companies for the past 20 years. He served as the Chief Financial Officer of Eyeonics Inc., acquired by Bausch & Lomb, Operational and financial roles with Vertos Medical, Inc., and Orthalign, Inc. Consulted for Intralase Corp., SenoRx, BioLucent, Vascular Control Systems, which included 2 IPO's and 4 acquisitions. CFO for Biopsys Medical, acquired by J&J.

  • Default avatar
    Harry Skinner
    Founder & Chief Medical Officer

    Dr. Skinner served as Professor of Orthopaedic Surgery in the UC system for over 20 years, including Chairman at UCI from 1994 to 2006 and now practices at St. Jude Medical in Fullerton, California. Dr. Skinner is a materials scientist with over 100 publications. He has experience with two start-ups, Norian (injectable bone substitute, sold to Synthes) and Kyphon (kyphoplasty, sold to Medtronic). He has also served as a panel member for the FDA.

  • Default avatar
    Tadashi Kaneko

    Tadashi S. Kaneko, Ph.D. is a mechanical engineer, biomedical engineer, and machinist. He has experience designing and fabricating equipment for bone research. A significant portion of Dr. Kaneko’s doctoral dissertation involved the development and evaluation of a radiation transport modeling method for predicting dose distributions in vertebrae injected with radioactive bone cement. Dr. Kaneko has 12 peer-reviewed publications and abstracts.

  • Default avatar
    Joyce Keyak

    Joyce Keyak, Ph.D. is a co-inventor of Spine-Rad Cement and the driving force for R&D of products and procedures related to internal radiation therapy (brachytherapy) for bone. Dr. Keyak has over 10 years of experience as an Associate Professor of Radiological Sciences, Orthopaedic Surgery, Biomedical Engineering, and Mechanical & Aerospace Engineering at UCI. She heads the Bone Biomechanics Lab. at UCI, and has over 50 peer-reviewed publications

  • Default avatar
    Varun Sehgal

    Varun Sehgal, Ph.D. is a medical physicist with experience developing brachytherapy techniques. He is an Assistant Professor of Radiation Oncology at UCI, is board certified in Therapeutic Radiological Physics by the American Board of Radiology. He also serves on the Special Brachytherapy Modalities Working Group of the American Association of Physicists in Medicine (AAPM). Dr. Sehgal has 20 publications & presentations at national meetings.

  • Default avatar
    Gary Mocnik
    R/A Q/A Consultant

    Mr. Mocnik has over 20 years of experience in developing and implementing QA Systems, RA strategies and submissions, and assuring compliance for companies in the medical device, diagnostic and pharma industries. He currently serves as VP RA/QA for Cianna Medical. Mr. Mocnik served as the VP of RA/QA for Refractec, the Director of RA/QA at Neurocare, and held senior management positions at Birtcher Medical Systems and Allergan Medical Optics.


  • Default avatar
    Wilson Sonsini Goodrich & Rosati

Previous Investors

  • Default avatar
    $760,000 DOD Research Grant
    Default avatar
    $100,000 Company Founders